Kenneth Kaitin

Kenneth Kaitin

Director/Board Member at CURIS, INC.

Net worth: 2 861 $ as of 31/07/2026

73 year
Consumer Services
Commercial Services
Technology Services

Profile

Kenneth I.
Kaitin
is currently an Independent Director at Curis, Inc. since 2003.
Also holds director positions at Bio-Tree Systems, Inc., Centerphase Solutions, Inc., and QCDx LLC.
Formerly served as Director at Phase Forward, Inc. from 2007 to 2010.
Served as Director at New England Healthcare Institute and Erevnos Corp.
Directed the Tufts Center for the Study of Drug Development from 1998 to 2020.
Was President of the Drug Information Association from 1997 to 1998.
Worked as Research Professor at Tufts University School of Medicine from 2008 to 2014.
Education includes graduate and doctorate degrees from Rochester Christian University and an undergraduate degree from Cornell University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/07/2026 570 ( 0.03% ) 2 861 $ 31/07/2026

Kenneth Kaitin active positions

CompaniesPositionStart
CURIS, INC. Director/Board Member 01/11/2003
Director/Board Member 25/06/2009
Director/Board Member -
Director/Board Member -

Former positions of Kenneth Kaitin

CompaniesPositionEnd
Director/Board Member 31/12/2020
Director/Board Member 11/08/2010
President 01/01/1998
Corporate Officer/Principal -
Erevnos Corp.
Director/Board Member -
See the detail of Kenneth Kaitin's experience

Training of Kenneth Kaitin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

53

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Consumer Services

Health Technology

Technology Services

Health Services

Technology Services

Consumer Services

Commercial Services

Commercial Services

Erevnos Corp.

Consumer Services

Commercial Services

Electronic Technology

  1. Stock Market
  2. Insiders
  3. Kenneth Kaitin